Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/2005
08/03/2005CN1649847A Method for producing optically active sulfoxide derivative
08/03/2005CN1649844A Isoquinoline derivatives
08/03/2005CN1649843A Novel chalcone derivatives and uses thereof
08/03/2005CN1649841A Piperidine derivative compound and drug containing the same compound as active ingredient
08/03/2005CN1649820A Compounds that modulate PPAR activity and methods for their preparation
08/03/2005CN1649819A Novel thyroid receptor ligands
08/03/2005CN1649627A Methods and conpositions for treating, preventing or delaying onset of a neoplasm
08/03/2005CN1649622A DNA vaccine against proliferating endothelial cells and methods of use thereof
08/03/2005CN1649616A Methods and compositions for the treatment of ischemia
08/03/2005CN1649611A Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
08/03/2005CN1649610A Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and DNA repair proc
08/03/2005CN1649607A A process for the extraction of anthocyanins from black rice and composition thereof
08/03/2005CN1649602A Re-epithelializing pharmaceutical compositions comprising xanthan gum
08/03/2005CN1649591A Tricyclic compounds useful as HIV reverse transcriptase inhibitors
08/03/2005CN1649583A Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
08/03/2005CN1649582A Amino-methyl substituted tetracycline compounds
08/03/2005CN1649581A Substituted 3-amino-thieno(2, 3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
08/03/2005CN1649574A Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
08/03/2005CN1649517A Soft drink replacer
08/03/2005CN1649513A Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
08/03/2005CN1647805A Health food having delaying senility and beautifying function and its preparing method
08/03/2005CN1647701A Method for producing soybean trypsin inhibitor concentration
08/03/2005CN1213143C Pharmacentical use of homoeotic hematoietic system reconstitution cell
08/03/2005CN1213070C Monoclonal antibodies directed against the G3BP protein and use
08/03/2005CN1213058C FAP-activated anti-tumor compounds
08/03/2005CN1213047C Puring derivatives inhibitors of tyrosine kinase SYK
08/03/2005CN1213046C Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors
08/03/2005CN1213045C Tyrosine kinase inhibitors
08/03/2005CN1213044C Amine and amide derivatives as ligands for neuropeptide YY5 receptor useful in treatment of obesity and other disorders
08/03/2005CN1213040C Serine protese inhibitors
08/03/2005CN1213038C Benzophenones as inhibitors of reverse transcriptase
08/03/2005CN1213036C Novel amide derivatives
08/03/2005CN1213033C Crystalline bis [(E)-7[4-(4-(4-fluorophenyl)-6-isopropy-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl] (3R,5S-3,5-dihydroxyhept-6-enoic acid] calcium salt
08/03/2005CN1213029C S-Ht receptor agonist and its preparing method for salt
08/03/2005CN1213028C Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl IV, processes for their preparation, and their use
08/03/2005CN1213025C 硫代酰胺衍生物 Thioamide derivatives
08/03/2005CN1213022C Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
08/03/2005CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors
08/03/2005CN1213017C Propynyl or diene diaryl compounds
08/03/2005CN1212839C Use of substituted pyrazoles in preparing medicine for treating allergies
08/03/2005CN1212835C Hydroxamate-containing cysteine and serine protease inhibitors
08/03/2005CN1212826C Topically applied idebenone-containing agent with protective and regenerative effect
08/02/2005US6925388 Heterocyclic nonnucleoside inhibitors of reverse transcriptase
08/02/2005US6924415 Identified as a target for therapeutic intervention due to its role in molecular events that lead to or contribute to cardiac hypertrophy and/or dilated cardiomyopathy
08/02/2005US6924392 Ortho, meta-substituted bisaryl compounds, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them
08/02/2005US6924376 Compounds, compositions and methods
08/02/2005US6924374 Modulators of dopamine neurotransmission
08/02/2005US6924357 Polypeptide encoded by a polynucleotide of given sequence; detecting the effect of a test compound on the production of mRNA; use in identifying agonists/antagonists that may be useful in therapy
08/02/2005US6924309 Modulation cystic fibrosis; antiinflammatory agents; antiallergens; rheumatic diseases; autoimmune diseases
08/02/2005US6924307 Metalloproteinase inhibitor; antiarthritic agents, osteoporosis; cardiovascular disorders; antitumor agents; autoimmune diseases
08/02/2005US6924305 Diazocine derivatives and their use as tryptase inhibitors
08/02/2005US6924304 Compounds such as N-((dimethylamino)acetyl)-1-methyl-N-(3, 4,5-trimethoxyphenyl)-1H-indole-5-sulfonamide for therapy of cancer
08/02/2005US6924301 Composition for treating or preventing arrhythmia
08/02/2005US6924300 Oxyiminoalkanoic acid derivatives
08/02/2005US6924297 Naphathalene derivatives which bind to the EP4 receptor
08/02/2005US6924295 Hetereocyclic amines such as 3-(5-(2-(2-(4-methylphenyl)-5-methyloxazol-4-yl)ethoxy)-1,2,3,4-tetrahydroquinolin-1-yl)propanoic acid ethyl ester, used as peroxisome proliferator activated receptor modulators; hyperlipemia; diabetis;
08/02/2005US6924292 Nitrogen compounds such as 2-(methylsulfinyl) N [3-(3,4,8,9-tetrahydro-6-methoxy-3,3,8,8-tetramethylfuro[2,3-h]isoquinolin-1-yl)phenyl]acetamide, used as phosphodiesterase inhibitors; antidiabetics; antiinflammatory agents
08/02/2005US6924290 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders
08/02/2005US6924289 Useful for treating or preventing a disorder or condition selected from hypertension, depression, anxiety, phobias, post trauma stress, sexual disfunction, eating disorder, obesity, Alzheimer's disease, Parkinson's disease etc.
08/02/2005US6924284 PARP inhibitors
08/02/2005US6924283 4-thioxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carbothioamides as antiviral agents
08/02/2005US6924282 5-(1,1-dioxido-1,2-thiazinan-2-yl)-n-(4-fluorobenzyl)-8-hydrox y-1,6-naphthyridine-7-carboxamide; preventing or treating hiv or aids
08/02/2005US6924280 Dipeptide derivatives
08/02/2005US6924278 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases
08/02/2005US6924276 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
08/02/2005US6924266 NTP-peptides and method for removal of tumors
08/02/2005US6924141 Inducing the effects of promoted signal transduction with protein and lithium chloride or mimicking via administration of agent that inhibits either catenin phosphorylation or kinase
08/02/2005US6924100 Nucleotide sequences coding preferential polypeptide for use in the treatment and diagnosis of cardiovascular disorders and headaches
08/02/2005US6923993 Process of isolating extract from the Euphorbia obesa plant and methods for using the same
08/02/2005US6923988 Solid carrier includes a hydrophililc surfactant and a drug
08/02/2005US6923965 comprises inhibitors of glycosaminoglycans; for wound healing and angiogenesis
08/02/2005US6923959 Method of pre-inducing a state of immune tolerance before organ transplantation
08/02/2005CA2362339C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
08/02/2005CA2362337C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
08/02/2005CA2325358C 7-¬(4'-trifluoromethyl-biphenyl-2-carbonyl)amino|-quinoline-3-carboxylic acid amides, and methods of inhibiting the secretion of apolipoprotein b
08/02/2005CA2321639C Bicyclo[2.2.1]heptanes and related compounds
08/02/2005CA2243199C Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
08/02/2005CA2190087C Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic activities
08/02/2005CA2170020C Retroviral protease inhibiting compounds
08/02/2005CA2154577C Novel inhibitors of adenosine monophosphate deaminase
08/02/2005CA2132537C Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists
07/2005
07/28/2005WO2005068624A1 Method of screening remedy for rheumatoid arthritis
07/28/2005WO2005068467A1 Novel fused-ring compound
07/28/2005WO2005067913A1 Lipase inhibitor
07/28/2005WO2005067904A1 Abca1 stabilizer
07/28/2005WO2003072035A8 Compositions and methods for the treatment of immune related diseases
07/28/2005US20050165243 Process for the production of an immunosuppressant
07/28/2005US20050165240 Chemical intermediates for production of sibutramine
07/28/2005US20050165227 Antiproliferative agents; gene overexpression
07/28/2005US20050165219 Related to the thymic stromal cotransporter subfamily; can be used as models for the development of and aid in the identification of therapeutic proteins that modulate transporter activity
07/28/2005US20050165116 ketones carrying electron withdrawing substituents alpha to the carbonyl functionality; phospholipase A2 inhibitor; potent in reducing eicosanoid production
07/28/2005US20050165113 (3S)-N-butyl-3-((2S)-2-(((4-fluorophenyl)sulfonyl)amino)-3-methylbutanoylamino)-5-methyl-2-oxohexanamide; calpain inhibition; Alzheimer's, osteoporosis, brain and eye disorders, ischemia
07/28/2005US20050165112 metalloproteinase inhibitory activity; N-hydroxy-5-ethoxymethyloxy -2(S)-methyl-4(S)-(4-phenoxybenzoyl)aminopentanamide or a pharmaceutical acceptable salt
07/28/2005US20050165106 Preferentially inhibit the inducible isoform of nitric oxide synthase
07/28/2005US20050165103 for enhancing the endogenous production of interleukin-10 (IL-10) and suppressing the production of interleukin-2 in mammalian cells or tissues; inhibiting the proliferation of stimulated peripheral mononuclear cells
07/28/2005US20050165098 Local anesthetic methods and kits
07/28/2005US20050165097 Comprising a local anesthetic, an alpha adrenergic receptor agonist and a low dose of an alpha adrenergic receptor antagonist, for reversing local anesthesia
07/28/2005US20050165091 includes a buffering agent to stabilize and maintain the pH below 9 in an aqueous dispersion; slow the degradation; shelf-life
07/28/2005US20050165087 Nf-kb inhibitors
07/28/2005US20050165086 Aminothiophene inhibitors of NF- kappa B inhibitors for treatment of diseases such as cancer or aids
1 ... 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 ... 1564